Lind, M J <br/><br/>
Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  1989 
 - 139-42 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/BF00692355  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--blood<br/>Chromatography, High Pressure Liquid<br/>Half-Life<br/>Humans<br/>Ifosfamide--administration & dosage<br/>Lung Neoplasms--blood<br/>Mesna--administration & dosage<br/>Middle Aged<br/>Obesity--metabolism<br/>Time Factors<br/>Tissue Distribution--drug effects